MRD Full Form in Medical term is Minimal Residual Disease. After cancer treatment, there should be only a few lingering cancer cells, a condition known as minimal residual illness. The patients may experience relapses due to the persistence of these cells.
These days, MRD may be quantified with the help of far more sensitive assays. Bone marrow samples could be analyzed with next-generation sequencing technology to detect genetic abnormalities. Even though there is no visible evidence of disease under a microscope, the presence of mutations indicates the presence of minimal residual disease.
Flow cytometry is another option for investigating the presence of aberrant proteins on the cell surface, and it can be used to the same samples. Experts can learn more about the number of lingering cancer cells by counting the ones in which aberrant proteins have been found. They regularly try to determine whether or not a patient exhibits MRD after standard treatment using these novel assays.
It’s hard to generalize because there are so many different kinds of blood cancer. Different MRD sufferers will have various reactions. In most cases, they need to undertake additional therapies for the greatest outcome if an individual has MRD.